Skip to content

Protease

DRAFT

This page is a work in progress and is subject to change at any moment.

TODO:

Proteases, or peptidases, represent a ubiquitous and functionally diverse superfamily of enzymes. Their primary function lies in the hydrolysis of peptide bonds within protein substrates, essentially acting as molecular sculptors that orchestrate a multitude of cellular activities through precise proteolysis. This targeted cleavage regulates critical processes underlying cellular physiology and development.

Biological relevance

Proteases play a pivotal role in maintaining cellular proteostasis. They are instrumental in:

  • Digestion: Within the digestive system, a cascade of proteases including pepsin, trypsin, and chymotrypsin facilitates the breakdown of dietary proteins into smaller peptides and amino acids for efficient absorption.
  • Protein Turnover: Proteases are essential for the regulated degradation of damaged, misfolded, or short-lived proteins, ensuring the proper functioning of the cellular proteome.
  • Signal Transduction: Proteolytic processing of signaling molecules by specific proteases activates or inactivates downstream pathways, influencing cellular responses to diverse stimuli.
  • Cell Cycle Regulation: Proteases orchestrate cell division by precisely cleaving regulatory proteins that govern cell cycle progression.
  • Extracellular Matrix Remodeling: Proteases are crucial for the dynamic remodeling of the extracellular matrix, a process essential for tissue development, wound healing, and cell migration.
  • Immune Response: Proteases participate in the immune system by processing antigen molecules into peptides for presentation to immune cells, facilitating a robust immune response.

Disease development

Tightly regulated proteolytic activity is essential for normal cellular function. However, aberrant protease activity can contribute to the pathogenesis of various diseases:

  • Neurodegenerative Disorders: Uncontrolled proteolysis by caspases and other proteases is implicated in the neurodegenerative processes observed in Alzheimer's disease, Parkinson's disease, and Huntington's disease.
  • Cancer: Cancer cells often exploit proteases to degrade components of the extracellular matrix, facilitating tumor invasion and metastasis. Additionally, proteases can contribute to tumor growth by activating signaling pathways promoting proliferation and survival.
  • Inflammatory Disorders: Excessive proteolytic activity by enzymes like metalloproteases can exacerbate tissue damage and inflammation in diseases like rheumatoid arthritis and inflammatory bowel disease.
  • Autoimmune Diseases: Protease malfunction can lead to the inappropriate degradation of healthy tissues, contributing to autoimmune pathologies like rheumatoid arthritis and systemic lupus erythematosus.

As a drug target

The multifaceted roles of proteases in physiology and disease make them attractive targets for drug development. Their suitability stems from several key advantages:

  • Specificity: Inhibitor design can target specific proteases based on their active site architecture and substrate recognition, minimizing off-target effects on other proteolytic processes.
  • Disease Relevance: Targeting dysregulated proteases offers a strategy to intervene in the pathological processes underlying various diseases.
  • Regulation Mechanisms: Many proteases are activated or inhibited by endogenous regulators, providing a framework for the development of drugs that modulate their activity.